Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men

Neuroscience Letters

Volumn 385, Issue 2, 2005, Pages 158-162

  Costa Mallen, Paola ^a   Costa, Lucio G ^a   Checkoway, Harvey ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Dopamine D2 receptor; Ever never smoking status; Gender difference; Gene gene interaction; Monoamine oxidase B

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE 2 RECEPTOR; TAQ POLYMERASE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; INTRONS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RISK; SEX DISTRIBUTION; SMOKING; WASHINGTON;

EID: 21844456618     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.05.035     Document Type: Article

References (29)

1. J. Balciuniene, L. Emilsson, L. Oreland, U. Pettersson, and E.E. Jazin Investigation of the functional effect of monoamine oxidase polymorphisms in human brain Hum. Genet. 110 2002 1 7
2. L.J. Bierut, J.P. Rice, H.J. Edenberg, A. Goate, T. Foroud, C.R. Cloninger, H. Begleiter, P.M. Conneally, R.R. Crowe, V. Hesselbrock, T.K. Li, J.I. Nurnberber Jr., B. Porjesz, M.A. Schuckit, and T. Reich Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking Am. J. Med. Genet. 4 2000 299 302
3. K. Castagnoli, S.J. Steyn, G. Magnin, C.J. Van Der Schyf, I. Fourie, A. Khalil, and N. Castagnoli Jr. Studies on the interaction of tobacco leaf and tobacco smoke constituents and monoamine oxidase Neurotox. Res. 4 2002 151 160
4. D.E. Comings Molecular heterosis as the eplanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density Mol. Psychiatry 4 1999 213 215
5. D.E. Comings, and K. Blum Reward deficiency syndrome: geneticaspects of behavioral disorders Prog. Brain Res. 126 2000 325 341
6. D.E. Comings, L. Ferry, S. Bradshaw-Robinson, R. Burchette, C. Chiu, and D. Muhleman The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking Pharmacogenetics 6 1996 73 79
7. P. Costa, H. Checkoway, D. Levy, T. Smith-Weller, G.M. Franklin, P.D. Swanson, and L.G. Costa Association of a polymorphism in intron 13 of the monoamine oxidase B with Parkinson disease Am. J. Med. Genet. 74 1997 154 156
8. P. Costa-Mallen, Z. Afsharinejad, S.N. Kelada, L.G. Costa, G.M. Franklin, P.D. Swanson, W.T. Longstreth Jr., H.-M.A. Viernes, F.M. Farin, T. Smith-Weller, and H. Checkoway DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls Mov. Disord. 19 2004 76 83
9. P. Costa-Mallen, L.G. Costa, T. Smith-Weller, G.M. Franklin, P.D. Swanson, and H. Checkoway Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interaction with cigarette smoking and MAO-B intron 13 polymorphism J. Neurol. Neurosurg. Psychiatry 69 2000 535 537
10. P. Costa-Mallen, S.N. Kelada, L.G. Costa, H. Checkoway, Characterization of the in-vitro transcriptional activity of polymorphic alleles of the human monoamine oxidase-B gene, Neurosci. Lett. (2005), in press.
11. J. Erblich, C. Lerman, D.W. Self, G.A. Diaz, and D.H. Bovbjerg Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms Pharmacogenomics J. 4 2004 102 109
12. J.S. Fowler, G. Logan, G.J. Wang, and N.D. Volkow Monoamine oxidase and cigarette smoking Neurotoxicology 24 2003 75 82
13. J.S. Fowler, N.D. Volkow, J. Logan, N. Pappas, P. King, R. MacGregor, C. Shea, V. Garza, and S.J. Gatley An acute dose of nicotine does not inhibit MAO-B in baboon brain in vivo Life Sci. 63 1998 19 23
14. J.S. Fowler, N.D. Volkow, G.J. Wang, N. Pappas, J. Logan, R. MacGregor, D. Alexoff, C. Shea, D. Schlyer, A.P. Wolf, D. Warner, I. Zezulkova, and R. Cilento Inhibition of monoamine oxidase B in the brain of smokers Nature 379 1996 733 736
15. H. Garpenstrand, J. Ekblom, K. Forslund, G. Rylander, and L. Oreland Platelet monoamine oxidase activity is related to MAOB intron 13 genotype J. Neural Transm. 107 2000 523 530
16. D.K. Grandy, M. Litt, L. Allen, J.R. Bunzow, M. Marchionni, H. Makam, L. Reed, R.E. Magenis, and O. Civelli The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP Am. J. Hum. Genet. 45 1989 778 785
17. A.C. Heath, K.M. Kirk, J.M. Meyer, and N.G. Martin Genetic and social determinants of initiation and age at onset of smoking in Australian twins Behav. Genet. 29 1999 395 407
18. M.A. Hernan, B. Takkouche, F. Caamano-Isorna, and J.J. Gestal-Otero A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease Ann. Neurol. 52 2002 276 284
19. H. Ito, N. Hamajima, K. Matsuo, K. Okuma, S. Sato, R. Ueda, and K. Tajima Monoamine oxidase polymorphisms and smoking behaviour in Japanese Pharmacogenetics 13 2003 73 79
20. E.C. Johnstone, P. Yudkin, S.E. Griffiths, A. Fuller, M. Murphy, and R. Walton The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population Addict. Biol. 9 2004 221 226
21. E.F. McKinney, R.T. Walton, P. Yudkin, A. Fuller, N.A. Haldar, D. Mant, M. Murphy, K.I. Welsh, and S.E. Marshall Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers Pharmacogenetics 10 2000 483 491
22. L. Oreland, and J. Hallman The correlation between platelet MAO activity and personality - a short review of findings and a discussion on possible mechanisms Prog. Brain Res. 106 1995 77 84
23. N.L. Pedersen, L. Oreland, C. Reynolds, and G.E. McClearn Importance of genetic effects for monoamine oxidase activity in thrombocytes in twins reared apart and twins reared together Psychiatry Res. 46 1993 239 251
24. T.V. Perneger What's wrong with Bonferroni adjustments BMJ 316 1998 1236 1238
25. T. Pohjalainen, J.O. Rinne, K. Nagren, P. Lehikoinen, K. Anttila, E.K. Syvalahti, and J. Hietala The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers Mol. Psychiatry 3 1998 256 260
26. P. Riederer, C. Konradi, G. Hebestreit, and M.B. Youdim Neurochemical perspectives to the function of monoamine oxidase Acta Neurol. Scand. 126 1989 41 45
27. *A1 and cigarette smoking in a United Kingdom population Pharmacogenetics 8 1998 125 128
28. M.R. Spitz, H. Shi, F. Yang, K.S. Hudmon, H. Jiang, R.M. Chamberlain, C.I. Amos, Y. Wan, P. Cinciripini, W.K. Hong, and X. Wu Case-control study of D2 dopamine receptor gene and smoking status in lung cancer patients J. Natl. Cancer Inst. 90 1998 358 363
29. J. Thompson, N. Thomas, A. Singleton, M. Piggott, S. Lloyd, E.K. Perry, C.M. Morris, R.H. Perry, I.N. Ferrier, and J.A. Court D2 dopamine receptor gene (DRD2) TaqI A polymorphism: reduced dopaminergic D2 receptor binding in the human striatum associated with the A1 allele Pharmacogenetics 7 1997 479 484